Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Therapeutic strategies for COVID-19: progress and lessons learned
2023 Standout
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
2023 Standout
Works of Aimee Wilkin being referenced
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial
2018
Chronic pruritus in HIV-positive patients in the southeastern United States: Its prevalence and effect on quality of life
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Aimee Wilkin | 596 | 350 | 297 | 48 | 989 | |
| Luciane Velasque | 561 | 376 | 160 | 68 | 1.1k | |
| Lakshmi Goparaju | 758 | 525 | 394 | 38 | 1.0k | |
| Elsa Heylen | 745 | 446 | 365 | 54 | 922 | |
| D. Scott Batey | 837 | 577 | 430 | 80 | 1.1k | |
| Paul Sereda | 797 | 675 | 261 | 85 | 1.0k | |
| Mirjam-Colette Kempf | 975 | 647 | 463 | 80 | 1.4k | |
| Helen‐Maria Lekas | 505 | 342 | 411 | 40 | 1000 | |
| Akshay Sharma | 515 | 399 | 201 | 60 | 887 | |
| Carol Dawson-Rose | 505 | 435 | 332 | 52 | 878 | |
| Sarah E. Woolf‐King | 481 | 620 | 406 | 50 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...